Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 16, 2009, Pages 6730-6735

  Van Montfoort, Nadine ^a   Camps, Marcel G ^a   Khan, Selina ^a   Filippov, Dmitri V ^b   Weterings, Jimmy J ^b   Griffith, Janice M ^c   Geuze, Hans J ^c   Van Hall, Thorbald ^a   Verbeek, J Sjef ^a   Melief, Cornelis J ^a   Ossendorp, Ferry ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antigen processing; Cross presentation; Endocytosis; Fc receptor; MHC class

Indexed keywords

ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CELL SURFACE; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOLOGY; IMMUNOLOGY; INTRACELLULAR SPACE; LYSOSOME; METABOLISM; PROTEIN STABILITY; TIME; ULTRASTRUCTURE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL COMPARTMENTATION; CELL DIFFERENTIATION; CELL MEMBRANE; CROSS-PRIMING; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTRACELLULAR SPACE; LYSOSOMES; MICE; PEPTIDES; PROTEIN STABILITY; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 66149116050     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900969106     Document Type: Article

References (39)

1. Melief CJ (2003) Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: Peaceful coexistence of cross-priming and direct priming? Eur J Immu-nol 33:2645-2654.
2. Shen L, Rock KL (2006) Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol 18:85-91.
3. Bevan MJ (2006) Cross-priming. Nat Immunol 7:363-365.
4. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252.
5. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667.
6. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ (2006) Ins and outs of dendritic cells. Int Arch Allergy Immunol 140:53-72.
7. Tacken PJ, de Vries IJ, Torensma R, Figdor CG (2007) Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting. Nat Rev Immunol 7:790-802.
8. Yewdell JW (2007) Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol 19:79-86.
9. Turley SJ, et al. (2000) Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522-527.
10. Kleijmeer M, et al. (2001) Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol 155:53-63.
11. Groothuis TA, Neefjes J (2005) The many roads to cross-presentation. J Exp Med 202:1313-1318.
12. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S (1999) Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1:362-368.
13. Guermonprez P, et al. (2003) ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425:397-402.
14. Houde M, et al. (2003) Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402-406.
15. Ackerman AL, Giodini A, Cresswell P (2006) A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25:607-617.
16. Kleijmeer MJ, et al. (2001) Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2:124-137.
17. Gromme M, et al. (1999) Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci USA 96:10326-10331.
18. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C (2007) Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316:612-616.
19. Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C (2008) Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 9:558-566.
20. Schuurhuis DH, et al. (2002) Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8-CTL responses in vivo. J Immunol 168:2240-2246.
21. Regnault A, et al. (1999) Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189:371-380.
22. Schuurhuis DH, et al. (2006) Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol 176:4573-4580.
23. Khan S, et al. (2007) Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells. J Biol Chem 282:21145-21159.
24. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-787.
25. Wilson NS, El Sukkari D, Villadangos JA (2004) Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103:2187-2195.
26. Storkus WJ, Zeh HJ, III, Salter RD, Lotze MT (1993) Identification of T-cell epitopes: Rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol 14:94-103.
27. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES (2005) Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630-1634.
28. Savina A, et al. (2006) NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126:205-218.
29. Ossendorp F, et al. (2005) Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J Immunol 174:7815-7822.
30. Garg S, et al. (2003) Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol 4:907-912.
31. Itano AA, Jenkins MK (2003) Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 4:733-739.
32. MartIn-Fontecha A, et al. (2003) Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J Exp Med 198:615-621.
33. Henrickson SE, et al. (2008) T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat Immunol 9:282-291.
34. Lipford GB, Bauer S, Wagner H, Heeg K (1995) In vivo CTL induction with point-substituted ovalbumin peptides: Immunogenicity correlates with peptide-induced MHC class I stability. Vaccine 13:313-320.
35. Winzler C, et al. (1997) Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 185:317-328.
36. Schuurhuis DH, et al. (2000) Immature dendritic cells acquire CD8- cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J Exp Med 192:145-150.
37. Sanderson S, Shastri N (1994) LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 6:369-376.
38. Ossendorp F, Mengede E, Camps M, Filius R, Melief CJ (1998) Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocom-patibility complex class II negative tumors. J Exp Med 187:693-702.
39. Geuze HJ, Slot JW, van der Ley PA, Scheffer RC (1981) Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections. J Cell Biol 89:653-665.